[1]CurrentPatentAssignee:QUANTABIODESIGN;UNIVERSITYOFWASHINGTON-US2013/52130,2013,A1Locationinpatent:Paragraph0310
[1]CurrentPatentAssignee:TAGWORKSPHARMACEUTICALSBV-US2013/272959,2013,A1Locationinpatent:Paragraph0140;0141
[1]CurrentPatentAssignee:TAGWORKSPHARMACEUTICALSBV-US2013/272959,2013,A1
[1]CurrentPatentAssignee:TAGWORKSPHARMACEUTICALSBV-US2013/272959,2013,A1
[1]Nunes,JoãoP.M.;Morais,Maurício;Vassileva,Vessela;Robinson,Eifion;Rajkumar,VineethS.;Smith,MarkE.B.;Pedley,R.Barbara;Caddick,Stephen;Baker,JamesR.;Chudasama,Vijay[ChemicalCommunications,2015,vol.51,#53,p.10624-10627]
Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562